Financials

  • Market Capitalization 5.31 M
  • Employee 19
  • Founded 1988
  • CEO David A. Dodd
  • Website www.geovax.com
  • Headquarter Delaware, United States
  • FIGI BBG000BGGJD8
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.19
Price to sales ratio
1.65

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4928
PULM
Pulmatrix, Inc. - Common Stock
1.48 USD-3.27%-3.90%-14.45%-69.98%5.41 M USD
4929
BRTX
BioRestorative Therapies, Inc. - Common Stock
0.21 USD-4.55%0.00%-19.23%-88.46%5.35 M USD
4934
BCAB
BioAtla, Inc. - Common Stock
3.14 USD+0.32%-3.09%-7.37%+630.23%5.23 M USD
4943
MLEC
Moolec Science SA - Ordinary Shares
6.81 USD0.00%-7.85%-4.22%+436.22%4.94 M USD

Frequently asked questions about GeoVax Labs, Inc. New

What is the GeoVax Labs, Inc. New stock price today?

The current price of GeoVax Labs, Inc. New (GOVX) is 0.72. Over the past 24 hours, the stock has changed by +14.29%. Follow the GOVX chart for real-time price dynamics.

What is the stock ticker of GeoVax Labs, Inc. New?

GeoVax Labs, Inc. New trades under the ticker GOVX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is GeoVax Labs, Inc. New stock going up?

GOVX has changed by +14.29% over the last week, -1.37% over the last month, and -50.34% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of GeoVax Labs, Inc. New?

GeoVax Labs, Inc. New currently has a market capitalization of 5.31 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were GeoVax Labs, Inc. New earnings last quarter?

Last quarter, GeoVax Labs, Inc. New reported earnings of -0.97 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was GeoVax Labs, Inc. New revenue for the last quarter?

GeoVax Labs, Inc. New reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was GeoVax Labs, Inc. New net income for the last quarter?

GeoVax Labs, Inc. New reported net income of -4.43 M for the last quarter. The previous quarter showed -5.26 M, which means net income changed by +15.88%.

How many employees does GeoVax Labs, Inc. New have?

As of the latest available data, GeoVax Labs, Inc. New has 19 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy GeoVax Labs, Inc. New stock?

You can buy GeoVax Labs, Inc. New (GOVX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in GeoVax Labs, Inc. New stock?

Investing in GeoVax Labs, Inc. New requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GOVX chart and related analysis on metatrader.com as part of your research.

GeoVax Labs, Inc. - Common Stock

GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated.

News